查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1931299

桡骨头切除植入市场按产品类型、材料、最终用户和分销管道划分，全球预测（2026-2032年）

Radial Head Resection Implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，桡骨头切除植入市场价值将达到 6,525 万美元，到 2026 年将成长至 7,172 万美元，到 2032 年将达到 1.079 亿美元，年复合成长率为 7.44%。

关键市场统计数据
基准年 2025 6525万美元
预计年份：2026年 7172万美元
预测年份 2032 1.079亿美元
复合年增长率 (%) 7.44%

本文重点介绍影响桡骨头切除植入开发和应用的临床需求、手术趋势和商业性因素。

桡骨头切除植入领域处于整形外科创新和复杂临床决策的交汇点，需要对器械设计、手术方法和相关人员的期望有深入的了解。本报告首先简要概述了需要桡骨头置换解决方案的临床背景，重点介绍了影响器械选择和手术技术应用的适应症、患者特征和术后目标。

分析临床实务、器材工程和医疗服务体系的变革，这些变革正在重塑桡骨头植入领域的竞争动态。

近年来，整个桡骨头植入生态系统经历了变革性的变化，重新定义了竞争优势，不再局限于渐进式的产品更新，而是从设备的设计、交付和支持方式等方面进行了系统性变革。生物材料科学的进步，包括表面处理和合金选择，提高了骨整合性和耐磨性，进而影响外科医师的选择和长期临床疗效。

美国关税政策展望至2025年：全面剖析近期发展如何重塑植入生态系的供应链、筹资策略与购买行为。

美国2025年前的关税调整前景，正在为桡骨头切除植入的製造商和经销商创造新的商业环境，促使相关人员重新评估其供应链布局和筹资策略。这些贸易措施的累积影响在采购行为中显而易见：买家对到岸成本和前置作业时间的波动更加敏感，采购规范也更加强调供应商多元化和尽可能使用国产产品。

详细的細項分析揭示了产品类型、材料选择、最终用户特征和分销管道如何共同决定产品定位和商业化优先顺序。

市场区隔洞察揭示了产品设计选择和分销策略与临床需求和客户期望的交汇点，突显了製造商面临的关键差异化挑战。在评估产品类型时，对于需要即时固定或牢固骨界面的情况，骨水泥型植入仍然具有价值；而对于那些优先考虑生物整合和长期骨保存的临床医生而言，非骨水泥型植入则更受欢迎。骨水泥型和非骨水泥型植入物之间的选择会影响手术器械、手术流程和训练需求。

从区域观点分析美洲、欧洲、中东和非洲以及亚太地区的需求驱动因素、监管复杂性和商业性要务，以指导市场进入和扩张。

区域趋势塑造了投资、临床应用和监管重点的整合领域，从而在美洲、欧洲、中东和非洲以及亚太地区形成了各自独特的战略要务。在美洲，高流量专科医疗中心的集中分布和先进的医保报销系统推动了对技术差异化植入和全面临床支援的需求。该地区的买家往往优先考虑临床证据、外科医生培训计画和一体化服务模式。

深入了解竞争态势、伙伴关係模式和能力投资，这些因素将决定哪些公司将在植入市场中获得临床应用和采购优势。

随着成熟的整形外科公司和专注于特定领域的新兴企业寻求不同的临床应用和商业性化路径，桡骨头植入领域的竞争动态正在不断演变。大规模跨国製造商往往利用其整合的销售团队、广泛的外科培训项目和多元化的产品系列来赢得医院合约并支持长期的临床研究。同时，规模小规模、更专注于特定领域的公司则倾向于在材料、模组化设计或特定手术适应症方面进行敏捷创新，以吸引早期采用的临床医生。

为产品、价值链和商业领导者提供切实可行的建议，以推动产品应用、确保业务永续营运，并在不断变化的植入环境中创造差异化价值。

为了抓住临床和商业性机会，产业领导者应采取一系列策略行动，兼顾短期韧性和中期差异化。首先，优先发展模组化产品设计，使其能够同时适用于有骨水泥和非骨水泥两种技术，这将拓宽临床应用范围，降低产品种类复杂性，并提高产品在不同手术环境中的普及率。

一种透明且可重复的调查方法，结合了对临床医生的访谈、技术审查、专家检验和情境分析，以支持策略洞察。

本报告的研究整合了多方面的资料收集和严格的检验通讯协定，以确保研究结果具有实证性和可操作性。主要研究包括对骨科医生、采购负责人和供应链经理进行结构化访谈，并辅以来自手术中心和医院的案例研究，以了解医疗设备的实际使用和采购趋势。次要研究涵盖监管文件、临床文献、标准文件和公共采购检验，以验证主要研究结果，并为技术评估奠定基础。

这份简明扼要的摘要重点阐述了产品品质卓越、临床协作和供应链韧性这三大综合优先事项，它们将决定该领域的长期成功。

总之，桡骨头切除植入领域正处于一个转折点，材料科学、外科技术的进步和商业模式的创新在此交汇融合，重新定义价值创造。能够将产品设计与临床工作流程相结合、投资外科医生培训并建立稳健供应链的製造商，将在各种临床环境中获得市场认可方面占据优势。对市场区隔进行策略性考量——平衡有骨水泥型和非有骨水泥型植入物、选择满足临床需求的材料以及为门诊手术中心和医院制定客製化的商业性策略——将决定其市场份额。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 桡骨头切除植入市场（依产品类型划分）

  • 水泥固位植入
  • 非骨水泥型植入

9. 桡骨头切除植入市场（依材料划分）

  • 钴铬
  • 不銹钢
  • 钛

第十章 桡骨头切除植入市场（依最终用户划分）

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院

第十一章 桡骨头切除植入市场（依分销管道划分）

  • 在线的
  • 离线

第十二章 桡骨头切除植入市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 桡骨头切除植入市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国桡骨头切除植入市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国桡骨头切除植入市场

16. 中国桡骨头切除植入市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acumed LLC
  • Arthrex Inc
  • Atlas Surgical
  • B. Braun Melsungen AG
  • CONMED Corporation
  • DePuy Synthes
  • Exactech Inc
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Narang Medical Limited
  • Orthofix Medical Inc
  • OsteoMed
  • RTI Surgical Holdings Inc
  • Sharma Orthopedic India Pvt Ltd
  • Siora Surgicals Pvt Ltd
  • Smith & Nephew Plc
  • Stryker Corporation
  • Tornier（now part of Stryker）
  • Wright Medical Group NV
  • XLO India
  • Zimmer Biomet Holdings Inc
Product Code: MRR-7B550E008E17

The Radial Head Resection Implant Market was valued at USD 65.25 million in 2025 and is projected to grow to USD 71.72 million in 2026, with a CAGR of 7.44%, reaching USD 107.90 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 65.25 million
Estimated Year [2026] USD 71.72 million
Forecast Year [2032] USD 107.90 million
CAGR (%) 7.44%

A focused introduction framing the clinical imperatives, surgical trends, and commercial forces shaping development and adoption of radial head resection implants

The radial head resection implant domain sits at the intersection of orthopedic innovation and complex clinical decision-making, requiring an informed view of device design, surgical approaches, and stakeholder expectations. This report opens with a concise orientation to the clinical context that necessitates radial head replacement solutions, emphasizing indications, patient profiles, and postoperative objectives that drive device selection and procedural adoption.

Clinicians increasingly balance functional restoration with implant longevity and soft-tissue preservation, prompting device developers to refine fixation mechanisms, surface engineering, and modularity. Concurrently, healthcare providers are recalibrating procurement and care pathways to optimize patient throughput and cost-effectiveness, which in turn informs product requirements and commercialization strategies. By situating product evolution within the realities of surgical workflows, regulatory oversight, and hospital economics, this introduction sets the stage for deeper analysis on how manufacturers, clinicians, and payers converge around performance, safety, and value in the radial head implant space.

An analysis of systemic shifts across clinical practice, device engineering, and care delivery that are reshaping competitive dynamics in the radial head implant sector

Recent years have seen transformative shifts that are redefining competitive advantage across the radial head implant ecosystem, moving beyond incremental product updates toward systemic changes in how devices are designed, delivered, and supported. Advances in biomaterials science, including surface treatments and alloy selection, are enabling improvements in osseointegration and wear resistance, which in turn influence surgeon preference and long-term clinical outcomes.

Simultaneously, minimally invasive techniques and enhanced imaging capabilities have altered procedural expectations, encouraging manufacturers to prioritize modularity and intraoperative flexibility. These clinical shifts coincide with structural changes in procurement and care delivery: ambulatory surgical centers are capturing a larger share of elective orthopedic procedures, and hospitals are consolidating purchasing to negotiate more favorable contracts. Finally, digital tools for surgical planning, postoperative monitoring, and remote training are creating new channels for product differentiation and customer engagement, driving a more service-oriented commercial model across the implant value chain.

A comprehensive view of how recent United States tariff developments through 2025 are reshaping supply chains, sourcing strategies, and procurement behavior across the implant ecosystem

Anticipated tariff adjustments in the United States through 2025 have created a new operational backdrop for manufacturers and distributors of radial head resection implants, prompting stakeholders to reassess supply chain footprints and sourcing strategies. The cumulative impact of these trade measures is evident in procurement behavior, where buyers are increasingly sensitive to landed costs and lead-time volatility, and in procurement specifications that emphasize supplier diversification and domestic content where feasible.

In response, many suppliers have accelerated nearshoring and capacity-building initiatives to mitigate exposure to import duties. This structural shift often involves higher upfront capital commitments but can yield greater resilience in production continuity and quality control. Meanwhile, distributors and health systems are re-evaluating inventory strategies to balance working capital constraints against potential supply disruptions. Regulatory and reimbursement environments further complicate this picture, as any cost pass-through to providers or patients pressures adoption decisions. Cumulatively, the tariff-related environment is catalyzing strategic realignment across manufacturing, logistics, and commercial negotiations, raising the bar for operational flexibility and cost management without supplanting the core clinical requirements that govern device selection.

Deep segmentation analysis revealing how product type, material choices, end-user characteristics, and distribution channels collectively determine product positioning and commercialization priorities

Segmentation insights illuminate where product design choices and channel strategies intersect with clinical requirements and customer expectations, revealing differentiated imperatives for manufacturers. When assessing product type, cemented implants remain relevant for cases requiring immediate fixation and where bone quality dictates a secure interface, whereas non-cemented implants appeal to clinicians prioritizing biological integration and long-term bone preservation; the choice between cemented and non-cemented approaches informs instrumentation, surgical workflow, and training needs.

Material selection further nuances competitive positioning: cobalt chromium alloys are favored where wear resistance and strength are paramount, stainless steel maintains a role for cost-sensitive constructs, and titanium offers superior biocompatibility and osseointegration potential for cases emphasizing bone affinity. End-user segmentation highlights operational and procurement differences between ambulatory surgical centers and hospitals; free-standing ambulatory surgical centers typically prioritize shorter procedures and streamlined inventories, while hospital-affiliated ASCs may leverage broader clinical networks and negotiated purchasing. Private hospitals often pursue specialized service lines and premium device offerings, while public hospitals emphasize cost containment and standardized product sets. Distribution channel choices also matter: direct sales relationships enhance clinical training and post-market surveillance capabilities for manufacturers, whereas third-party distributors provide scale, geographic reach, and logistical capabilities that facilitate rapid market penetration. Together, these segmentation dimensions create a matrix of strategic trade-offs that manufacturers must navigate to match product attributes, commercial models, and service offerings to distinct clinical environments and procurement behaviors.

A regional perspective on demand drivers, regulatory complexity, and commercial imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that guide market entry and expansion

Regional dynamics shape where investment, clinical adoption, and regulatory emphasis converge, producing distinct strategic imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of high-volume specialist centers and advanced reimbursement systems drives demand for technologically differentiated implants and comprehensive clinical support; buyers in this region often value clinical evidence, surgeon training programs, and integrated service models.

The Europe, Middle East & Africa region presents a diverse landscape where regulatory harmonization in some markets contrasts with procurement constraints in others, necessitating flexible pricing strategies and adaptable commercial approaches. Local manufacturing and distributor partnerships can be critical to winning tenders and establishing long-term relationships with both public and private hospitals. The Asia-Pacific region combines rapid procedural volume growth with variable regulatory clarity, creating opportunities for scalable manufacturing, cost-competitive materials, and partnerships with regional distributors to accelerate adoption. Across all regions, cross-border supply chain considerations, reimbursement landscapes, and clinical practice standards influence the pace of adoption and the criteria by which implants are evaluated, underscoring the importance of regionally tailored strategies for product development and market entry.

Insight into competitive postures, partnership models, and capability investments that determine which companies gain clinical adoption and procurement advantage in the implant marketplace

Competitive dynamics in the radial head implant arena are evolving as established orthopedic firms and specialized challengers pursue different paths to clinical relevance and commercial traction. Larger multinational manufacturers often leverage integrated salesforces, broad surgical training programs, and diversified portfolios to secure hospital contracts and support long-term clinical studies, while smaller, specialized firms tend to focus on nimble innovation in materials, modularity, or niche surgical indications that attract early-adopter clinicians.

Partnerships between device makers and contract manufacturers have become more prominent as companies seek to balance speed-to-market with capital efficiency. Additionally, strategic collaborations with distributor networks or value-added service providers allow manufacturers to extend geographic reach without heavy upfront investment in local infrastructure. Mergers and acquisitions remain a mechanism for rapid capability expansion, particularly to acquire novel surface technologies, instrumentation systems, or regulatory dossiers. Across the competitive landscape, successful players are those that align product differentiation with robust clinical evidence, deliver comprehensive surgeon education, and demonstrate supply chain reliability, particularly in an environment where procurement teams scrutinize total cost of ownership and operational continuity.

Action-oriented, pragmatic recommendations for product, supply chain, and commercial leaders to drive adoption, resilience, and differentiated value in a shifting implant ecosystem

Industry leaders should pursue a portfolio of strategic actions that balance near-term resilience with medium-term differentiation to capture clinical and commercial opportunities. First, prioritizing modular product designs compatible with both cemented and non-cemented techniques expands clinical applicability and reduces SKU complexity, thereby increasing the probability of adoption across diverse surgical settings.

Second, investing in a materials roadmap that leverages titanium for biocompatibility while maintaining options in cobalt chromium or stainless steel for specific mechanical requirements enables targeted value propositions for distinct surgeon preferences. Third, supply chain strategies should emphasize dual sourcing, strategic nearshoring, and inventory optimization to mitigate tariff-driven cost volatility and logistics disruptions. Fourth, cultivating direct clinical relationships through hands-on surgeon training, outcome registries, and post-market surveillance builds trust and accelerates uptake in premium settings, while partnering with third-party distributors can accelerate scale into cost-sensitive or geographically dispersed markets. Fifth, commercial teams should develop segmented pricing and reimbursement strategies aligned to ambulatory surgical centers versus hospital procurement dynamics, and tailor commercial models to free-standing ASCs, hospital-affiliated ASCs, private hospitals, and public institutions. Finally, leaders must incorporate digital enablement-surgical planning tools, remote training, and post-operative monitoring-to differentiate the offering and create recurring value streams beyond the implant itself.

A transparent and reproducible research methodology combining primary clinician interviews, secondary technical review, expert validation, and scenario-based analysis to underpin strategic insights

The research underpinning this report integrates multi-source data collection and rigorous validation protocols to ensure insights are evidence-based and actionable. Primary research included structured interviews with orthopedic surgeons, procurement officers, and supply chain managers, supplemented by case studies of surgical centers and hospitals to capture real-world device use and purchasing dynamics. Secondary research encompassed regulatory filings, clinical literature, standards documentation, and publicly available procurement records to triangulate primary insights and anchor technical assessments.

Analytical methods combined qualitative synthesis with scenario analysis to explore outcomes under different regulatory, tariff, and adoption pathways. Expert panels reviewed preliminary findings to validate assumptions and highlight emerging signals in clinical practice and supplier strategy. Quality assurance procedures included cross-checking interview transcripts, verifying citations, and documenting methodological limitations; where data gaps existed, conservative assumptions were applied and clearly annotated. The methodology aims to provide decision-makers with transparent, reproducible insights, while acknowledging that evolving clinical evidence and policy changes may alter specific dynamics over time.

A concise concluding synthesis highlighting the integrated priorities of product excellence, clinical engagement, and supply chain resilience that determine long-term success in the sector

In summary, the radial head resection implant field is at an inflection point where material science, surgical technique evolution, and commercial model innovation converge to redefine value creation. Manufacturers that align product design with clinical workflows, invest in surgeon education, and build resilient supply chains will be better positioned to capture adoption across differentiated care settings. Strategic attention to segmentation-balancing cemented and non-cemented options, selecting materials that match clinical requirements, and customizing commercial approaches for ambulatory surgical centers and hospitals-will determine market relevance.

Moreover, regional nuances in procurement, regulation, and clinical practice necessitate tailored entry strategies that respect local dynamics while leveraging global capabilities. The cumulative effects of tariff changes and supply chain pressures underscore the need for operational flexibility and closer collaboration between manufacturers, distributors, and healthcare providers. Ultimately, success in this sector will depend on an integrated approach that combines product performance, evidence generation, and robust commercial execution to meet surgeon expectations and deliver reliable patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radial Head Resection Implant Market, by Product Type

  • 8.1. Cemented Implant
  • 8.2. Non-Cemented Implant

9. Radial Head Resection Implant Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Stainless Steel
  • 9.3. Titanium

10. Radial Head Resection Implant Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Radial Head Resection Implant Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Radial Head Resection Implant Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radial Head Resection Implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radial Head Resection Implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radial Head Resection Implant Market

16. China Radial Head Resection Implant Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acumed LLC
  • 17.6. Arthrex Inc
  • 17.7. Atlas Surgical
  • 17.8. B. Braun Melsungen AG
  • 17.9. CONMED Corporation
  • 17.10. DePuy Synthes
  • 17.11. Exactech Inc
  • 17.12. Globus Medical Inc
  • 17.13. Integra LifeSciences Holdings Corporation
  • 17.14. Medtronic Plc
  • 17.15. MicroPort Scientific Corporation
  • 17.16. Narang Medical Limited
  • 17.17. Orthofix Medical Inc
  • 17.18. OsteoMed
  • 17.19. RTI Surgical Holdings Inc
  • 17.20. Sharma Orthopedic India Pvt Ltd
  • 17.21. Siora Surgicals Pvt Ltd
  • 17.22. Smith & Nephew Plc
  • 17.23. Stryker Corporation
  • 17.24. Tornier (now part of Stryker)
  • 17.25. Wright Medical Group N.V.
  • 17.26. XLO India
  • 17.27. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)